You’ve finished drafting the patent application for a critical, clinical stage invention. The scientific team wrote up the examples and they even included comparative data. You’ve finalized the claims and specification....more
10/13/2020
/ Clinical Trials ,
Enablement Inquiries ,
Intellectual Property Protection ,
Inventions ,
Nonobvious ,
Patent Applications ,
Patents ,
Pharmaceutical Patents ,
Post-Grant Review ,
Treatment Method Patents ,
Written Descriptions
You’ve thought long and hard about how your company’s clinical stage invention is novel over anything that’s ever been done before. Your analysis is finished, right? Not even close. The novelty barrier to patentability can be...more
9/24/2020
/ Intellectual Property Litigation ,
Intellectual Property Protection ,
Inventions ,
Obviousness ,
Patent Applications ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prior Art ,
Research and Development
Congratulations! Your team has made a critical discovery based on its analysis of your company’s clinical data. You want to file a patent application so that your company can secure patent rights for that discovery. Simple,...more
9/17/2020
/ Clinical Trials ,
Inherently Distinctive ,
Intellectual Property Protection ,
Inventions ,
Notice of Allowance ,
Novelty ,
Patent Applications ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prior Art ,
Treatment Method Patents
Under the first-to-file patent system in place in the U.S. and globally, a publication that pre-dates an effective filing date can preclude the patenting of an invention. ...more